Author | Bessa, Theolis Costa Barbosa | |
Author | Aragão, Erika Santos de | |
Author | Guimarães, Jane Mary Medeiros | |
Author | Almeida, Bethânia de Araújo | |
Access date | 2018-02-26T18:46:41Z | |
Available date | 2018-02-26T18:46:41Z | |
Document date | 2017 | |
Citation | BESSA, T. C. B. et al. R&D in Vaccines Targeting Neglected Diseases: An Exploratory Case Study Considering Funding for Preventive Tuberculosis Vaccine Development from 2007 to 2014. BioMed Research International, ID 4765719, 2017. | pt_BR |
ISSN | 2314-6133 | pt_BR |
URI | https://www.arca.fiocruz.br/handle/icict/24949 | |
Sponsorship | National Institute of Science and Technology of Innovation onDiseases of Neglected Populations (INCT-IDPN), | pt_BR |
Language | eng | pt_BR |
Publisher | Hindawi Publishing Corporation | pt_BR |
Rights | open access | pt_BR |
Subject in Portuguese | Doenças negligenciadas | pt_BR |
Subject in Portuguese | Tuberculose | pt_BR |
Subject in Portuguese | Vacinas contra a tuberculose | pt_BR |
Subject in Portuguese | Pesquisa | pt_BR |
Subject in Portuguese | Ensaios clínicos como assunto | pt_BR |
Title | R&D in Vaccines Targeting Neglected Diseases: An Exploratory Case Study Considering Funding for Preventive Tuberculosis Vaccine Development from 2007 to 2014 | pt_BR |
Type | Article | pt_BR |
DOI | 10.1155/2017/4765719 | |
Abstract | Based on an exploratory case study regarding the types of institutions funding the research and development to obtain new tuberculosis vaccines, this article intends to provoke discussion regarding the provision of new vaccines targeting neglected disease. Although our findings and discussion are mainly relevant to the case presented here, some aspects are more generally applicable, especially regarding the dynamics of development in vaccines to prevent neglected diseases. Taking into account the dynamics of innovation currently seen at work in the vaccine sector, a highly concentrated market dominated by few multinational pharmaceutical companies, we feel that global PDP models can play an important role throughout the vaccine development cycle. In addition, the authors call attention to issues surrounding the coordination of actors and resources in the research, development, manufacturing, and distribution processes of vaccine products arising from PDP involvement. | pt_BR |
Affilliation | Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil | pt_BR |
Affilliation | Federal University of Bahia. Institute of Collective Health. Salvador, BA, Brazil | pt_BR |
Affilliation | Federal University of Southern Bahia. Institute of Humanities Arts and Sciences. Itabuna, BA, Brazil | pt_BR |
Affilliation | Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil | pt_BR |
Subject | Neglected Diseases | pt_BR |
Subject | Tuberculosis | pt_BR |
Subject | Tuberculosis Vaccines | pt_BR |
Subject | Research | pt_BR |
Subject | Clinical trials as subject | pt_BR |